MetaADEDB 2.0 @ LMMD
Nitroglycerin
(SNIOPGDIGTZGOP-UHFFFAOYSA-N)
Structure
SMILES
[O-][N+](=O)OC(CO[N+](=O)[O-])CO[N+](=O)[O-]
Type(s)
Approved; Investigational
ATC code(s)
C01DA02; C01DA52; C05AE01
Molecular Formula:
C3H5N3O9
Molecular Weight:
227.087
Log P:
0.5495
Hydrogen Bond Acceptor:
0
Hydrogen Bond Donor:
0
TPSA:
165.15
CAS Number(s):
55-63-0; 27906-99-6
Synonym(s)
1.
Nitroglycerin
2.
Glyceryl Trinitrate
3.
Anginine
4.
Dynamite
5.
Gilustenon
6.
Nitrangin
7.
Nitro-Bid
8.
Nitro-Dur
9.
Nitrocard
10.
Nitroderm
11.
Nitroderm TTS
12.
Nitroglyn
13.
Nitrol
14.
Nitrolan
15.
Nitrong
16.
Nitrospan
17.
Nitrostat
18.
Perlinganit
19.
Susadrin
20.
Sustac
21.
Sustak
22.
Sustonit
23.
Transderm Nitro
24.
Tridil
25.
Trinitrin
26.
Trinitrolong
27.
Nitro Bid
28.
Nitro Dur
29.
NitroBid
30.
NitroDur
31.
Trinitrate, Glyceryl
External Link(s)
MeSHD005996
PubChem Compound4510
ChEBI28787
CHEMBLCHEMBL730
DrugBankDB00727
DrugCentral1952
IUPHAR/BPS Guide to PHARMACOLOGY7053
KEGGcpd:C07455
dr:D00515
Therapeutic Target DatabaseD07YDE
D00ZHQ
D0YW4P
ZINC8214625
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 306
Canada Vigilance: 26
Canada Vigilance
US FAERS
2HeadacheFAERS: 94
Canada Vigilance: 26

View details

CTD
SIDER
Canada Vigilance
US FAERS
3HypotensionFAERS: 86
Canada Vigilance: 19

View details

CTD
SIDER
Canada Vigilance
US FAERS
4Product quality issueFAERS: 68US FAERS
5Product solubility abnormalFAERS: 54US FAERS
6Chest PainFAERS: 46
Canada Vigilance: 8

View details

CTD
OFFSIDES
Canada Vigilance
US FAERS
7SyncopeFAERS: 36
Canada Vigilance: 7

View details

CTD
SIDER
Canada Vigilance
US FAERS
8DizzinessFAERS: 34
Canada Vigilance: 14
3085698CTD
SIDER
Canada Vigilance
US FAERS
9Pharmaceutical product complaintFAERS: 34US FAERS
10Myocardial InfarctionFAERS: 32
Canada Vigilance: 4

View details

CTD
Canada Vigilance
US FAERS
11Medication ErrorFAERS: 26
Canada Vigilance: 3
Canada Vigilance
US FAERS
12BradycardiaFAERS: 25
Canada Vigilance: 3

View details

CTD
OFFSIDES
SIDER
Canada Vigilance
US FAERS
13Cardiac ArrestFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
14Burning sensationFAERS: 24
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
15NauseaFAERS: 24
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
16MalaiseFAERS: 20
Canada Vigilance: 3
Canada Vigilance
US FAERS
17Angina PectorisFAERS: 18
Canada Vigilance: 9

View details

CTD
SIDER
Canada Vigilance
US FAERS
18Incorrect dose administeredFAERS: 18US FAERS
19Product taste abnormalFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
20VomitingFAERS: 16
Canada Vigilance: 5
1903583
3928252
18800963
CTD
SIDER
Canada Vigilance
US FAERS
21PresyncopeFAERS: 15US FAERS
22Application site erythemaFAERS: 14
Canada Vigilance: 8
Canada Vigilance
SIDER
US FAERS
23Application site rashFAERS: 14
Canada Vigilance: 14
Canada Vigilance
US FAERS
24No adverse eventFAERS: 14US FAERS
25Product adhesion issueFAERS: 13
Canada Vigilance: 6
Canada Vigilance
US FAERS
26Product substitution issueFAERS: 12
Canada Vigilance: 37
Canada Vigilance
US FAERS
27Product use in unapproved indicationFAERS: 12US FAERS
28Product use issueFAERS: 12US FAERS
29HypersensitivityFAERS: 11
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
30PainFAERS: 11
Canada Vigilance: 1
7736873
9221864
9839827
CTD
OFFSIDES
Canada Vigilance
US FAERS
31TachycardiaFAERS: 11

View details

CTD
SIDER
US FAERS
32Application site pruritusFAERS: 10
Canada Vigilance: 6
Canada Vigilance
SIDER
US FAERS
33Drug administration errorFAERS: 10US FAERS
34Drug ineffective for unapproved indicationFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
35FatigueFAERS: 10
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
36Product physical issueFAERS: 9US FAERS
37Accidental overdoseFAERS: 8US FAERS
38Application site irritationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
39Application site painFAERS: 8
Canada Vigilance: 6
Canada Vigilance
US FAERS
40Contraindicated product administeredFAERS: 8US FAERS
41ErythemaFAERS: 8
Canada Vigilance: 18
Canada Vigilance
SIDER
US FAERS
42Feeling abnormalFAERS: 8SIDER
US FAERS
43Skin irritationFAERS: 8
Canada Vigilance: 4
Canada Vigilance
US FAERS
44AstheniaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
45Expired product administeredFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
46Incorrect drug administration durationFAERS: 7US FAERS
47PalpitationsFAERS: 7
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
48Poor quality drug administeredFAERS: 7US FAERS
49PruritusFAERS: 7
Canada Vigilance: 23
Canada Vigilance
SIDER
US FAERS
50Ventricular FibrillationFAERS: 73160229CTD
US FAERS
51Acute myocardial infarctionFAERS: 6OFFSIDES
US FAERS
52Application site reactionFAERS: 6
Canada Vigilance: 35
Canada Vigilance
SIDER
US FAERS
53Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
54Cold sweatFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
55Drug effect incompleteFAERS: 6US FAERS
56OverdoseFAERS: 6OFFSIDES
US FAERS
57Therapeutic response unexpectedFAERS: 6US FAERS
58Accidental exposure to productFAERS: 5US FAERS
59Cerebrovascular accidentFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
60Drug dose omissionFAERS: 5US FAERS
61Drug effect delayedFAERS: 5US FAERS
62Incorrect product storageFAERS: 5US FAERS
63Therapy non-responderFAERS: 5US FAERS
64Violence-related symptomFAERS: 5US FAERS
65Wrong technique in product usage processFAERS: 5US FAERS
66Adverse eventFAERS: 4US FAERS
67Altered state of consciousnessFAERS: 4US FAERS
68Application site burnFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
69AtaxiaFAERS: 418800963CTD
US FAERS
70DehydrationFAERS: 4OFFSIDES
US FAERS
71Device FailureFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
72Device malfunctionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
73DiscomfortFAERS: 4US FAERS
74DisorientationFAERS: 4US FAERS
75Drug dispensing errorFAERS: 4US FAERS
76HypoxiaFAERS: 46785177
9412885
CTD
OFFSIDES
SIDER
US FAERS
77LethargyFAERS: 41903583CTD
US FAERS
78Memory impairmentFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
79NasopharyngitisFAERS: 4OFFSIDES
US FAERS
80Product storage errorFAERS: 4US FAERS
81SomnolenceFAERS: 4SIDER
US FAERS
82SwellingFAERS: 4US FAERS
83ThrombocytopeniaFAERS: 4US FAERS
84Unresponsive to stimuliFAERS: 4US FAERS
85AngioplastyFAERS: 3US FAERS
86Atrial FibrillationFAERS: 3US FAERS
87Atrioventricular BlockFAERS: 38225663CTD
SIDER
US FAERS
88Chest discomfortFAERS: 3SIDER
US FAERS
89Coronary Artery DiseaseFAERS: 33141188CTD
US FAERS
90DysgeusiaFAERS: 3US FAERS
91DysphoniaFAERS: 3OFFSIDES
US FAERS
92EpistaxisFAERS: 3US FAERS
93FlushingFAERS: 3
Canada Vigilance: 2
1910019
3134314
9648986
CTD
SIDER
Canada Vigilance
US FAERS
94Hypertensive emergencyFAERS: 3US FAERS
95Intentional product misuseFAERS: 3US FAERS
96Lip swellingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
97Mental status changesFAERS: 3US FAERS
98Product label confusionFAERS: 3US FAERS
99Product packaging issueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Sinus bradycardiaFAERS: 3OFFSIDES
US FAERS
101Tongue discomfortFAERS: 3US FAERS
102VertigoFAERS: 3
Canada Vigilance: 1
11395995CTD
SIDER
Canada Vigilance
US FAERS
103Wrong technique in drug usage processFAERS: 3US FAERS
104AgeusiaFAERS: 22492914CTD
US FAERS
105AmnesiaFAERS: 2US FAERS
106AngerFAERS: 2OFFSIDES
US FAERS
107Anorectal discomfortFAERS: 2US FAERS
108Application site drynessFAERS: 2US FAERS
109Application site scabFAERS: 2US FAERS
110Application site vesiclesFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
111Back PainFAERS: 2US FAERS
112Back disorderFAERS: 2US FAERS
113BlindnessFAERS: 2US FAERS
114Blood glucose increasedFAERS: 2US FAERS
115CellulitisFAERS: 2OFFSIDES
US FAERS
116Cerebral InfarctionFAERS: 2US FAERS
117Coma scale abnormalFAERS: 2US FAERS
118DeliriumFAERS: 2US FAERS
119Disease recurrenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
120Expired drug administeredFAERS: 2US FAERS
121Extra dose administeredFAERS: 2US FAERS
122Inappropriate schedule of product administrationFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
123Incorrect product administration durationFAERS: 2US FAERS
124Incorrect storage of drugFAERS: 2US FAERS
125Intentional drug misuseFAERS: 2US FAERS
126Intentional product use issueFAERS: 2US FAERS
127Intercepted medication errorFAERS: 2US FAERS
128Intercepted product dispensing errorFAERS: 2US FAERS
129Local reactionFAERS: 2US FAERS
130MediastinitisFAERS: 2US FAERS
131NecrosisFAERS: 2US FAERS
132Occupational exposure to productFAERS: 2US FAERS
133PancytopeniaFAERS: 2US FAERS
134PneumoniaFAERS: 2US FAERS
135Posterior reversible encephalopathy syndromeFAERS: 2US FAERS
136Product container issueFAERS: 2US FAERS
137Product label issueFAERS: 2US FAERS
138SepsisFAERS: 2US FAERS
139Sexual DysfunctionFAERS: 2US FAERS
140ShockFAERS: 2SIDER
US FAERS
141StressFAERS: 2OFFSIDES
US FAERS
142Thermal burnFAERS: 2US FAERS
143Unmasking of previously unidentified diseaseFAERS: 2US FAERS
144Urinary RetentionFAERS: 2US FAERS
145UrticariaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
146Vulvovaginal burning sensationFAERS: 2US FAERS
147Wrong drug administeredFAERS: 2US FAERS
148Acute Coronary SyndromeFAERS: 110958127
15005775
CTD
US FAERS
149Alanine Aminotransferase IncreasedFAERS: 1US FAERS
150AlopeciaFAERS: 1US FAERS
151Anal abscessFAERS: 1US FAERS
152Anaphylactic shockFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
153AngioedemaFAERS: 120084849CTD
SIDER
US FAERS
154AnxietyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
OFFSIDES
US FAERS
155AphasiaFAERS: 1US FAERS
156AphoniaFAERS: 1US FAERS
157Application site eczemaFAERS: 1US FAERS
158Application site erosionFAERS: 1US FAERS
159Application site exfoliationFAERS: 1US FAERS
160Application site scarFAERS: 1US FAERS
161Application site urticariaFAERS: 1US FAERS
162Application site warmthFAERS: 1US FAERS
163ArthralgiaFAERS: 1US FAERS
164ArthritisFAERS: 1OFFSIDES
US FAERS
165AsthmaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
166AtopyFAERS: 1US FAERS
167Bladder dysfunctionFAERS: 1US FAERS
168BlepharospasmFAERS: 1US FAERS
169Blood creatine increasedFAERS: 1US FAERS
170Breakthrough PainFAERS: 1US FAERS
171BronchitisFAERS: 1OFFSIDES
US FAERS
172BruxismFAERS: 1OFFSIDES
US FAERS
173Carpal Tunnel SyndromeFAERS: 1US FAERS
174ChillsFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
175ColitisFAERS: 1US FAERS
176Contraindicated product prescribedFAERS: 1US FAERS
177Depressed moodFAERS: 1US FAERS
178Dermatitis HerpetiformisFAERS: 1US FAERS
179Device computer issueFAERS: 1US FAERS
180Device occlusionFAERS: 1US FAERS
181Documented hypersensitivity to administered drugFAERS: 1US FAERS
182Drug ToleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
183Drug administered to patient of inappropriate ageFAERS: 1US FAERS
184Drug dispensed to wrong patientFAERS: 1US FAERS
185Drug exposure during pregnancyFAERS: 1US FAERS
186Drug label confusionFAERS: 1US FAERS
187Drug prescribing errorFAERS: 1US FAERS
188DyspepsiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
US FAERS
189EczemaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
OFFSIDES
SIDER
US FAERS
190Electrocardiogram abnormalFAERS: 1US FAERS
191Epigastric discomfortFAERS: 1US FAERS
192Erectile dysfunctionFAERS: 11737261CTD
US FAERS
193Erection increasedFAERS: 1US FAERS
194ExcoriationFAERS: 1OFFSIDES
US FAERS
195Facial PainFAERS: 1US FAERS
196FibromyalgiaFAERS: 1US FAERS
197FrustrationFAERS: 1US FAERS
198General physical health deteriorationFAERS: 1US FAERS
199GlaucomaFAERS: 1US FAERS
200Head BangingFAERS: 1US FAERS
201Head discomfortFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
202HyperacusisFAERS: 1US FAERS
203Hypertensive crisisFAERS: 1US FAERS
204Inadequate analgesiaFAERS: 1US FAERS
205Inappropriate schedule of drug administrationFAERS: 1US FAERS
206IncoherentFAERS: 1US FAERS
207IncontinenceFAERS: 1OFFSIDES
US FAERS
208Incorrect dose administered by deviceFAERS: 1US FAERS
209Incorrect route of product administrationFAERS: 1US FAERS
210InfarctionFAERS: 1US FAERS
211InfectionFAERS: 1SIDER
US FAERS
212InfluenzaFAERS: 1US FAERS
213Intentional dose omissionFAERS: 1US FAERS
214Intercepted drug dispensing errorFAERS: 1US FAERS
215Joint injuryFAERS: 1OFFSIDES
US FAERS
216Joint swellingFAERS: 1US FAERS
217LeukocytosisFAERS: 1US FAERS
218Limb operationFAERS: 1US FAERS
219Malignant HypertensionFAERS: 1OFFSIDES
US FAERS
220Maternal exposure during pregnancyFAERS: 1US FAERS
221Mechanical complication of implantFAERS: 1US FAERS
222Metanephrine urine increasedFAERS: 1US FAERS
223Migraine with AuraFAERS: 111168608
15288408
16024898
CTD
US FAERS
224Mood swingsFAERS: 1US FAERS
225MyocarditisFAERS: 1US FAERS
226Neck PainFAERS: 1US FAERS
227Neonatal disorderFAERS: 1US FAERS
228NephrolithiasisFAERS: 1OFFSIDES
US FAERS
229Nonspecific reactionFAERS: 1US FAERS
230Normetanephrine urine increasedFAERS: 1US FAERS
231Ocular discomfortFAERS: 1US FAERS
232OliguriaFAERS: 1US FAERS
233Oral papuleFAERS: 1US FAERS
234OsteoporosisFAERS: 1US FAERS
235Oxygen saturation increasedFAERS: 1US FAERS
236PancreatitisFAERS: 1OFFSIDES
US FAERS
237PapuleFAERS: 1US FAERS
238Poor quality product administeredFAERS: 1US FAERS
239Poor quality sleepFAERS: 1US FAERS
240Prescription drug used without a prescriptionFAERS: 1US FAERS
241Procedural complicationFAERS: 1US FAERS
242Product administered to patient of inappropriate ageFAERS: 1US FAERS
243Product administration errorFAERS: 1US FAERS
244Product barcode issueFAERS: 1US FAERS
245Product complaintFAERS: 1
Canada Vigilance: 4
Canada Vigilance
US FAERS
246Product contamination physicalFAERS: 1US FAERS
247Product expiration date issueFAERS: 1US FAERS
248Product packaging confusionFAERS: 1US FAERS
249Product shape issueFAERS: 1US FAERS
250Product tamperingFAERS: 1US FAERS
251Pulmonary arterial pressure decreasedFAERS: 1US FAERS
252PurulenceFAERS: 1US FAERS
253Purulent dischargeFAERS: 1US FAERS
254Respiratory DepressionFAERS: 1US FAERS
255Respiratory FailureFAERS: 1US FAERS
256Respiratory arrestFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
257Respiratory distressFAERS: 1US FAERS
258RetchingFAERS: 1US FAERS
259Retinal DetachmentFAERS: 1US FAERS
260Retinal Vein OcclusionFAERS: 1US FAERS
261Right ventricular failureFAERS: 1US FAERS
262Rubber sensitivityFAERS: 1US FAERS
263ScreamingFAERS: 1US FAERS
264Skin UlcerFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
265Skin test positiveFAERS: 1US FAERS
266SneezingFAERS: 1US FAERS
267Soft tissue necrosisFAERS: 1US FAERS
268Subcutaneous AbscessFAERS: 1US FAERS
269Sudden Cardiac DeathFAERS: 1US FAERS
270Tablet physical issueFAERS: 1US FAERS
271Tension HeadacheFAERS: 1US FAERS
272Therapeutic product ineffectiveFAERS: 1US FAERS
273Therapeutic response unexpected with drug substitutionFAERS: 1US FAERS
274Therapy cessationFAERS: 1US FAERS
275Throat cancerFAERS: 1US FAERS
276TinnitusFAERS: 1OFFSIDES
US FAERS
277Tongue blisteringFAERS: 1US FAERS
278Trigeminal NeuralgiaFAERS: 1US FAERS
279Unevaluable eventFAERS: 1US FAERS
280VasospasmFAERS: 1US FAERS
281Visual ImpairmentFAERS: 1SIDER
US FAERS
282Weight decreasedFAERS: 1US FAERS
283West Nile viral infectionFAERS: 1US FAERS
284Wrong patient received medicationFAERS: 1US FAERS
285Abdominal PainSIDER
286Abdominal colicSIDER
287Abducens Nerve Diseases1903583
6416043
CTD
288AbscessOFFSIDES
289Acid refluxOFFSIDES
290AcidosisOFFSIDES
291Acquired porphyriaOFFSIDES
292Actinic keratosisOFFSIDES
293ActinomycosisOFFSIDES
294Acute kidney injury12243603CTD
295AgitationSIDER
296AkinesiaOFFSIDES
297Altitude Sickness18800963CTD
298AlveoloplastyOFFSIDES
299Amnesia, Transient Global18349207CTD
300AmphetaminesOFFSIDES
301AmyloidosisOFFSIDES
302Anaphylactoid ReactionCanada Vigilance: 2Canada Vigilance
SIDER
303Angina pectoris aggravatedSIDER
304Angina, Unstable3127076
3137075
CTD
305Anuria8225663CTD
306Aortic AneurysmOFFSIDES
307Apnea2124178CTD
OFFSIDES
308Application site inflammationCanada Vigilance: 1Canada Vigilance
309Arterial insufficiencyOFFSIDES
310ArthropathyOFFSIDES
311AtherosclerosisOFFSIDES
312AuraOFFSIDES
313Biopsy bone abnormalOFFSIDES
314Blood GlucoseOFFSIDES
315Blood Platelet Disorders7625621
9389267
CTD
316Blood and lymphatic system disordersSIDER
317Blood cholesterolOFFSIDES
318Blood creatine phosphokinase increasedOFFSIDES
319Blood glucose decreasedOFFSIDES
320Blood glucose fluctuationOFFSIDES
321Blood iron increasedOFFSIDES
322Blood potassium increasedOFFSIDES
323Blood potassiumOFFSIDES
324Blood pressure inadequately controlledOFFSIDES
325Blood sodiumOFFSIDES
326Blood thyroid stimulating hormoneOFFSIDES
327Blood triglycerides increasedOFFSIDES
328Brain Edema18800963CTD
329Brain Ischemia8401937CTD
330Brain natriuretic peptide increasedOFFSIDES
331Bundle-Branch Block10475830CTD
332Cardiac FlutterOFFSIDES
333Central nervous system lesionOFFSIDES
334Cerebral Hemorrhage1458106CTD
335Cerebral PalsyOFFSIDES
336Cerebral atrophyOFFSIDES
337Cervicobrachial syndromeOFFSIDES
338Chemical burn of skinCanada Vigilance: 1Canada Vigilance
339Chemical burns of eyeCanada Vigilance: 1Canada Vigilance
340Choking sensationOFFSIDES
341Cholangiocarcinoma8968066CTD
342Cholecystitis infectiveOFFSIDES
343CholecystitisOFFSIDES
344Choroid Diseases12055481CTD
345ChromaturiaOFFSIDES
346Chronic Obstructive Airway DiseaseOFFSIDES
347CirrhosisOFFSIDES
348Cluster Headache

View details

CTD
349ColectomyOFFSIDES
350ConfabulationOFFSIDES
351Congenital tricuspid valve incompetenceOFFSIDES
352Cor pulmonaleOFFSIDES
353Coronary Occlusion8164149CTD
354Coronary Stenosis3110237
3421167
CTD
355Creatinine renal clearance decreasedOFFSIDES
356Cubital Tunnel SyndromeOFFSIDES
357Culture wound positiveOFFSIDES
358CyanosisCanada Vigilance: 2Canada Vigilance
SIDER
359DeafnessOFFSIDES
360DebridementOFFSIDES
361Decreased LibidoOFFSIDES
362DemyelinationOFFSIDES
363Depressed Level of ConsciousnessCanada Vigilance: 1Canada Vigilance
364DermatitisCanada Vigilance: 2Canada Vigilance
SIDER
365Device breakageCanada Vigilance: 1Canada Vigilance
366Device deployment issueCanada Vigilance: 1Canada Vigilance
367Device ineffectiveCanada Vigilance: 1Canada Vigilance
368Device physical property issueCanada Vigilance: 1Canada Vigilance
369Device use errorCanada Vigilance: 1Canada Vigilance
370DiabetesOFFSIDES
371Diabetes mellitus inadequate controlOFFSIDES
372DiarrheaOFFSIDES
373Diplopia6416043CTD
374DiverticulumOFFSIDES
375DrowsinessSIDER
376Drug withdrawal headacheOFFSIDES
377Dysmenorrhea11915580CTD
378Dyspnea12771913
15564710
CTD
379Edema1425939
11701602
CTD
380Electrocardiogram ST-T changeOFFSIDES
381Emotional distressOFFSIDES
382Enterococcal infectionOFFSIDES
383Enzyme abnormalityOFFSIDES
384Escherichia urinary tract infectionOFFSIDES
385Extravasation of Diagnostic and Therapeutic Materials2865615CTD
386Eye InfectionOFFSIDES
387Factor VIII inhibitionOFFSIDES
388Fatty LiverOFFSIDES
389Feeling ColdOFFSIDES
390Fixed drug eruptionSIDER
391Flat affectOFFSIDES
392FlatulenceOFFSIDES
393Fluid overloadOFFSIDES
394Frostbite18800963CTD
395Gastrointestinal Diseases3985522CTD
396Gastrointestinal PainSIDER
397Gastrointestinal infectionOFFSIDES
398Gene MutationOFFSIDES
399Genital burning sensationOFFSIDES
400Genital erosionOFFSIDES
401GranulomaOFFSIDES
402Headache Disorders, Primary10960046CTD
403Heart Block6407806CTD
404Heart failure

View details

CTD
405Hematuria8225663CTD
406Hemiplegia6792715CTD
407Hemorrhage8225663CTD
408Hemorrhoids7736873CTD
409Heparin-induced thrombocytopeniaOFFSIDES
410Hepatitis12243603CTD
OFFSIDES
411Hyperalgesia

View details

CTD
412HypercapniaOFFSIDES
413Hyperemia

View details

CTD
414HyperpneaSIDER
415Hypertrophic CardiomyopathyOFFSIDES
416HyperventilationSIDER
417Hypesthesia9648986CTD
418Hypotension, Orthostatic8634922
10696890
CTD
419HypotensiveSIDER
420HypoxemiaSIDER
421Iatrogenic injuryOFFSIDES
422ImmobileSIDER
423Impaired gastric emptyingOFFSIDES
424Implantable defibrillator insertionOFFSIDES
425InfestationSIDER
426Infusion site mobility decreasedOFFSIDES
427Injection site dermatitisOFFSIDES
428Injection site urticariaOFFSIDES
429Intention tremorOFFSIDES
430Intestinal ObstructionCanada Vigilance: 1Canada Vigilance
431Intracranial Hypertension1448188
3928252
6775054
CTD
432Intraoperative Complications9990214CTD
433Iodine uptake increasedOFFSIDES
434Ischemia9523545CTD
435Kidney FailureOFFSIDES
436Left Ventricular HypertrophyOFFSIDES
437Left atrial dilatationOFFSIDES
438Life expectancy shortenedOFFSIDES
439LightheadednessSIDER
440Lip erosionOFFSIDES
441Liver Neoplasms, Experimental8968066CTD
442Localised skin reactionSIDER
443Low Back Pain11915580CTD
444Lupus pneumonitisOFFSIDES
445Lymphocyte percentage decreasedOFFSIDES
446MaculeCanada Vigilance: 1Canada Vigilance
447Malignant ascitesOFFSIDES
448Malignant tumour excisionOFFSIDES
449Memory Disorders19923525CTD
450Metabolic acidosisOFFSIDES
451Methemoglobinemia3537620CTD
452Migraine Disorders

View details

CTD
453Mucosal erosionOFFSIDES
454Muscle WeaknessOFFSIDES
455Muscle necrosisOFFSIDES
456MyelodysplasiaOFFSIDES
457Myeloma recurrenceOFFSIDES
458Myocardial Ischemia

View details

CTD
459Myocardial Reperfusion Injury9188292CTD
460Nephrogenic Fibrosing DermopathyOFFSIDES
461NervousnessCanada Vigilance: 1Canada Vigilance
462NeuralgiaOFFSIDES
463Nodular regenerative hyperplasiaOFFSIDES
464Nodule on extremityOFFSIDES
465Occupational Diseases3917307
6442006
11395995
CTD
466Oral mucosal exfoliationOFFSIDES
467OrthopneaOFFSIDES
468OsteomyelitisOFFSIDES
469Pain, Postoperative15832742CTD
470PallorCanada Vigilance: 1Canada Vigilance
OFFSIDES
SIDER
471Papilledema1903583CTD
472Paroxysmal Hemicrania17645760CTD
473Pericarditis lupusOFFSIDES
474PericarditisOFFSIDES
475Peripheral swellingCanada Vigilance: 1Canada Vigilance
476Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
477PharyngitisSIDER
478Phlebitis2865615CTD
479PneumothoraxOFFSIDES
480Post procedural fistulaOFFSIDES
481Post procedural infectionOFFSIDES
482Postoperative Complications2515460
6804108
11554966
CTD
483Postoperative ileusOFFSIDES
484Pre-Eclampsia17322376CTD
485Product lot number issueCanada Vigilance: 1Canada Vigilance
486Protein total increasedOFFSIDES
487Pseudotumor Cerebri1903583CTD
488Pulmonary Edema9645186CTD
489Pulmonary HypertensionOFFSIDES
490Pulmonary congestionOFFSIDES
491PurpuraCanada Vigilance: 1Canada Vigilance
492Quality of life decreasedOFFSIDES
493RalesOFFSIDES
494Rash erythematousCanada Vigilance: 5Canada Vigilance
495Rebound hypertensionSIDER
496Rectal polypOFFSIDES
497RednessSIDER
498Reflex bradycardiaSIDER
499Reflex tachycardiaSIDER
500Renal cystOFFSIDES
501Reperfusion Injury8869312CTD
502Restrictive pulmonary diseaseOFFSIDES
503Retinal Artery Occlusion12055481CTD
504Retrosternal discomfortSIDER
505Rhabdomyolysis12243603CTD
506RhinitisSIDER
507RhonchiOFFSIDES
508Seizures17543232CTD
509SequestrectomyOFFSIDES
510SinusitisOFFSIDES
511Sjogren's SyndromeOFFSIDES
512Skin graft failureOFFSIDES
513Skin lacerationCanada Vigilance: 1Canada Vigilance
514Skin lesionCanada Vigilance: 1Canada Vigilance
OFFSIDES
515Skin necrosisOFFSIDES
516Skin reactionCanada Vigilance: 4Canada Vigilance
SIDER
517Spasm9431903
11016328
11379694
CTD
518Speech Disorders3928252CTD
519Sphincter of Oddi Dysfunction9431903
11379694
CTD
520Splenic InfarctionOFFSIDES
521Stevens-Johnson SyndromeOFFSIDES
522StomatitisSIDER
523StuporCanada Vigilance: 1Canada Vigilance
524Subarachnoid Hemorrhage15198873CTD
525Substance Withdrawal Syndrome

View details

CTD
526SweatingSIDER
527Syringe issueCanada Vigilance: 1Canada Vigilance
528Tachycardia, Ventricular10719974CTD
529TachyphylaxisCanada Vigilance: 1Canada Vigilance
530Terminal stateOFFSIDES
531Therapeutic product effect decreasedCanada Vigilance: 4Canada Vigilance
532Throbbing HeadacheSIDER
533Thrombophlebitis8748367CTD
534Thrombosis in deviceOFFSIDES
535Tobacco userOFFSIDES
536Tolerance developmentSIDER
537Troponin increasedOFFSIDES
538UlcerOFFSIDES
539Urinary tract infection staphylococcalOFFSIDES
540Vascular bypass graftOFFSIDES
541Vasodilation procedureSIDER
542VasodilationSIDER
543Ventricular Dysfunction, Left

View details

CTD
544Vision Disorders1903583CTD
545Visual disturbanceSIDER
546Vulvovaginal painCanada Vigilance: 1Canada Vigilance
547Water IntoxicationOFFSIDES
548Weight GainOFFSIDES
549Withdrawal hypertensionSIDER
550Wound dehiscenceOFFSIDES
551anaphylaxis20084849CTD
552effusionOFFSIDES
553fibromaOFFSIDES
554furuncleOFFSIDES
555nervous system disorderSIDER
556skin abrasionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.